Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop

Open access
Hua, Yichao, Vella, Gerlanda, Rambow, Florian, Allen, Elizabeth, Antoranz Martinez, Asier, Duhamel, Marie, Takeda, Akira, Jalkanen, Sirpa, Junius, Steffie, Smeets, Ann, Nittner, David, Dimmeler, Stefanie, Hehlgans, Thomas, Liston, Adrian, Bosisio, Francesca Maria, Floris, Giuseppe, Laoui, Damya, Hollmén, Maija, Lambrechts, Diether, Merchiers, Pascal, Marine, Jean-Christophe, Schlenner, Susan, Bergers, Gabriele · 2022 · Cancer Cell

Abstract

The lack of T-cell infiltrates is a major obstacle to effective immunotherapy in cancer.Conversely, the formation of tumor-associated tertiary-lymphoid-like structures (TA-TLLS), which are the local site of humoral and cellular immune responses against cancers, are associated with good prognosis and have recently been detected in Immune Checkpoint Blockade (ICB)responding patients.However, how these lymphoid aggregates develop remains poorly understood.By employing single-cell transcriptomics, endothelial fate mapping, and functional multiplex immune profiling, we demonstrate that antiangiogenic immune-modulating therapies evoke transdifferentiation of postcapillary venules into inflamed high-endothelial venules (HEV) via LT/LTβR signaling.In turn, tumor-HEVs boost intratumoral lymphocyte influx and foster permissive lymphocyte niches for PD1 -and PD1 + TCF1 + CD8 T cell progenitors that differentiate into GrzB + PD1 + CD8 T effector cells.Tumor-HEVs require continuous CD8 and NK cell-derived signals revealing that tumor-HEV maintenance is actively sculpted by the adaptive immune system through a feed-forward loop. In BriefHua & Vella et al. reveal that effective antiangiogenic immunotherapy differentiates postcapillary venules into high-endothelial venules (HEV) by lymphotoxin beta receptor activation emanating from CD8 T and NK cell-derived signals.TU-HEVs establish perivascular niches in which TCF1 + PD1 + lymphocytes expand and produce cytotoxic PD1 + TIM3 + lymphocytes that may facilitate anti-tumoral immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2022.11.002

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 169

Metadata

Authors
Hua, Y., Vella, G., Rambow, F., Allen, E., Antoranz Martinez, A., Duhamel, M., Takeda, A., Jalkanen, S., Junius, S., Smeets, A., Nittner, D., Dimmeler, S., Hehlgans, T., Liston, A., Bosisio, F. M., Floris, G., Laoui, D., Hollmén, M., Lambrechts, D., Merchiers, P., Marine, J.-C., Schlenner, S., & Bergers, G.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2022-12
Volume
40
Issue
12
Pages
1600-1618.e10
ISSN
1535-6108 (ISSN-L)
OpenAlex
W4309825668
Cited by
169
References
29
FWCI
11.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop. https://app.cochat.ai/papers/10.1016/j.ccell.2022.11.002
The paper
Hua, Y., Vella, G., Rambow, F., Allen, E., Antoranz Martinez, A., Duhamel, M., Takeda, A., Jalkanen, S., Junius, S., Smeets, A., Nittner, D., Dimmeler, S., Hehlgans, T., Liston, A., Bosisio, F. M., Floris, G., Laoui, D., Hollmén, M., Lambrechts, D., . . . Bergers, G. (2022). Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop. Cancer Cell. https://doi.org/10.1016/j.ccell.2022.11.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.